Impact of different tissue dissociation protocols on endothelial cell recovery from developing lungs.

Activin A and CCR2 regulate the function of macrophages in testicular fibrosis caused by experimental autoimmune orchitis

Effect of depletion of GPRC5C from smooth muscle cells (SMC) on gene expression in mice

Identification of mitochondrial RNAs [1]

Identification of mitochondrial RNAs in brown adipose tissue

Identification of mitochondrial RNAs [II]

Influenza virus decreases albumin uptake and megalin expression in alveolar epithelial cells

Deep RNA sequencing analysis after Malat1 silencing in mouse HL1 cells

The regional distribution of resident immune cells shapes distinct immunological environments along the murine epididymis

GLI1+ cells are a source of repair-supportive mesenchymal cells (RSMCs) during airway epithelial regeneration

Genome-wide maps of Pol II pSer5 state in lung smooth muscle cells

Next Generation Sequencing Facilitates Quantitative Analysis of control smooth muscle cells and Tet3-inactivation smooth muscle cells transcriptomes

RNA sequencing of blood-brain barrier (BBB) microvessels from mice with hematogenous pneumococcal meningtis

ScRNA-seq of CD45 positive cells

RNAseq dataset of murine NVU cells post ischemic stroke isolated using the SGD method from the same starting material.

Recombinant FGF10-induced de novo alveologenesis in neonatal mice after hyperoxia exposure is associated with enhanced AT2’s resident mesenchymal cell niche activity

Effects of DNA topoisomerase inhibitor acriflavine on endothelial gene expression and chromatin accessibility (RNA-Seq)

Effects of DNA topoisomerase inhibitor acriflavine on endothelial gene expression and chromatin accessibility

Transcriptome profiling of murine cardiomyocytes after treatment with recombinant murine Leukemia inhibitory factor (mLIF), murine Oncostatin M (mOSM) and human-like Oncostatin M orthologue (hlOSM).

Transcriptional regulation in primary mouse brain microvascular endothelial cells following apical or basolateral pharmacological treatment with S1P or S1P4 agonist in C57B/6J wildtype versus global S1P4 KO mice